La maladie de Parkinson au Canada (serveur d'exploration) - Checkpoint (PascalFrancis)

Index « PascalFr.i » - entrée « Lévodopa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Lésion < Lévodopa < Lévétiracétam  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 133.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000308 (2010) Marc Morissette [Canada] ; Pershia Samadi [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Nancy Belanger [Canada] ; Thérèse Di Paolo [Canada]Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys
000322 (2010) Pierre-Luc Tremblay [Canada] ; Marc-Andre Bedard [Canada] ; Dominic Langlois [Canada] ; Pierre J. Blanchet [Canada] ; Martin Lemay [Canada] ; Maxime Parent [Canada]Movement chunking during sequence learning is a dopamine-dependant process: a study conducted in Parkinson's disease
000323 (2010) Daniella Rylander [Suède] ; Martin Parent [Canada] ; Sean S. O'Sullivan [Royaume-Uni] ; Sandra Dovero [France] ; Andrew J. Lees [Royaume-Uni] ; Erwan Bezard [France] ; Laurent Descarries [Canada] ; M. Angela Cenci [Suède]Maladaptive Plasticity of Serotonin Axon Terminals in Levodopa-Induced Dyskinesia
000327 (2010) Galit Kleiner-Fisman [Canada] ; Andres Lozano [Canada] ; Elena Moro [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada]Long-Term Effect of Unilateral Pallidotomy on Levodopa-Induced Dyskinesia
000328 (2010) Cory Toth [Canada] ; Kim Breithaupt [Canada] ; SHAOHUA GE [Canada] ; YANJUN DUAN [Canada] ; Joan M. Terris [Canada] ; Anita Thiessen [Canada] ; Samuel Wiebe [Canada] ; Douglas W. Zochodne [Canada] ; Oksana Suchowersky [Canada]Levodopa, Methylmalonic Acid, and Neuropathy in Idiopathic Parkinson Disease
000338 (2010) Rena K. Mann [Canada] ; Roderick Edwards [Canada] ; Julie Zhou [Canada] ; Mandar Jog [Canada] ; Christian Duval [Canada]Intra- and inter-limb coherency during stance in non-dyskinetic and dyskinetic patients with Parkinson's disease
000340 (2010) Fabrizio Stocchi [Italie] ; Olivier Rascol [France] ; Karl Kieburtz [États-Unis] ; Werner Poewe [Autriche] ; Joseph Jankovic [États-Unis] ; Eduardo Tolosa [Espagne] ; Paulo Barone [Italie] ; Anthony E. Lang [Canada] ; C. Warren Olanow [États-Unis]Initiating Levodopa/Carbidopa Therapy With and Without Entacapone in Early Parkinson Disease: The STRIDE-PD Study
000356 (2010) Janis M. Miyasaki [Canada]Evidence-based initiation of dopaminergic therapy in Parkinson's disease
000357 (2010) Ron Levy [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; Jonathan O. Dostrovsky [Canada]Event-related desynchronization of motor cortical oscillations in patients with multiple system atrophy
000360 (2010) Sarah C. Lidstone [Canada] ; Michael Schulzer [Canada] ; Katherine Dinelle [Canada] ; Edwin Mak [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Raul De La Fuente-Fernandez [Canada] ; Anthony G. Phillips [Canada] ; A. Jon Stoessl [Canada]Effects of Expectation on Placebo-Induced Dopamine Release in Parkinson Disease
000361 (2010) Bazoumana Ouattara [Canada] ; Fabrizio Gasparini [Suisse] ; Marc Morissette [Canada] ; Laurent Gregoire [Canada] ; Pershia Samadi [Canada] ; Baltazar Gomez-Mancilla [Suisse] ; Thérèse Di Paolo [Canada]Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys
000362 (2010) Tom H. Johnston [Canada] ; Anne Van Der Meij [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Effect of Histamine H2 Receptor Antagonism on Levodopa-Induced Dyskinesia in the MPTP-Macaque Model of Parkinson's Disease
000384 (2010) B. Ouattara [Canada] ; D. Hoyer [Suisse] ; L. Gregoire [Canada] ; M. Morissette [Canada] ; F. Gasparini [Suisse] ; B. Gomez-Mancilla [Suisse] ; T. Di Paolo [Canada]CHANGES OF AMPA RECEPTORS IN MPTP MONKEYS WITH LEVODOPA-INDUCED DYSKINESIAS
000393 (2010) André Bonnici [Canada] ; Carola-Ellen Ruiner [Canada] ; Lyne St-Laurent [Canada] ; David Hornstein [Canada]An Interaction Between Levodopa and Enteral Nutrition Resulting in Neuroleptic Malignant-Like Syndrome and Prolonged ICU Stay
000421 (2009) P. A. Guertin [Canada] ; C. Brochu [Canada]Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient
000446 (2009) I. A. Prescott [Canada] ; J. O. Dostrovsky [Canada] ; E. Moro [Canada] ; M. Hodaie [Canada] ; A. M. Lozano [Canada] ; W. D. Hutchison [Canada]Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients
000449 (2009) S. J. Palmer [Canada] ; L. Eigenraam [Canada] ; T. Hoque [Canada] ; R. G. Mccaig [Canada] ; A. Troiano [Canada] ; M. J. Mckeown [Canada]LEVODOPA-SENSITIVE, DYNAMIC CHANGES IN EFFECTIVE CONNECTIVITY DURING SIMULTANEOUS MOVEMENTS IN PARKINSON'S DISEASE
000475 (2009) Robert A. Hauser [États-Unis] ; Michel Panisset [Canada] ; Giovanni Abbruzzese [Italie] ; Linda Mancione [États-Unis] ; Nalina Dronamraju [États-Unis] ; Algirdas Kakarieka [Suisse]Double-Blind Trial of Levodopa/Carbidopa/Entacapone Versus Levodopa/Carbidopa in Early Parkinson's Disease
000478 (2009) Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada]Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study
000499 (2009) Connie Marras [Canada] ; Anthony E. Lang [Canada] ; Shirley W. Eberly [États-Unis] ; David Oakes [États-Unis] ; Stanley Fahn [États-Unis] ; Steven R. Schwid [États-Unis] ; Christopher Hyson [Canada] ; Ira Shoulson [États-Unis]A Comparison of Treatment Thresholds in Two Large Parkinson's Disease Clinical Trial Cohorts
000500 (2008) Laurent Gregoire [Canada] ; Arash Rassoulpour [États-Unis] ; Paolo Guidetti [États-Unis] ; Pershia Samadi [Canada] ; Paul J. Bedard [Canada] ; Emanuela Izzo [Italie] ; Robert Schwarcz [États-Unis] ; Therese Di Paolo [Canada]Prolonged kynurenine 3-hydroxylase inhibition reduces development of levodopa-induced dyskinesias in parkinsonian monkeys

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/PascalFr.i -k "Lévodopa" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/PascalFr.i  \
                -Sk "Lévodopa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Lévodopa
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022